Stopping lithium safely means tapering gradually over weeks to months rather than quitting abruptly, because rapid discontinuation sharply increases the risk of mood episode relapse, especially mania. Research consistently shows that more than half of people who stop lithium experience a new episode within ten weeks of stopping, and the risk of that happening is much lower when the dose is reduced slowly. The process involves coordination with a prescriber, regular monitoring, and a plan for what to do if symptoms return, but the specifics vary depending on why you are stopping and how long you have been on the medication.
Why Stopping Lithium Abruptly Is So Risky
The single most important thing to understand about lithium discontinuation is that stopping suddenly carries a greater risk of relapse than the natural course of bipolar disorder itself. That sounds counterintuitive, but the data are clear: abrupt withdrawal seems to trigger manic episodes at a rate that exceeds what would be expected if the person had never taken lithium at all. One landmark analysis found that the time to a new manic episode after stopping lithium was only about 2.7 months, whereas depressive recurrence took a median of 14 months. More than half of all new episodes clustered in the first ten weeks after stopping.1PubMed. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder A separate review confirmed that the risk of manic recurrence in the first weeks after discontinuation is higher than what the natural history of the illness would predict.2PubMed. Short-term sequelae of lithium discontinuation
The suspected mechanism behind this rebound is neurochemical. One hypothesis is that long-term lithium use changes receptor sensitivity in the brain, and when the drug is removed suddenly, the system overshoots. Case reports describe hypomanic or manic episodes emerging within days of abrupt lithium withdrawal, consistent with a receptor supersensitivity model.3Indian Journal of Psychiatry. Hypomania following Abrupt Lithium withdrawal Animal research has not fully confirmed this picture. One rat study found no rebound surge in dopamine release after lithium withdrawal, suggesting the mechanism is more complex than simple neurotransmitter overshoot.4PubMed. Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat Regardless of which brain pathway is responsible, the clinical pattern is well established: fast discontinuation means higher risk.
What Counts as “Gradual” Tapering
There is no single universally agreed-upon tapering schedule for lithium, but the research consistently draws a line between abrupt stops and slow reductions. In one study of people who stopped lithium and later restarted it, those who failed to respond on restarting had tapered over a median of just one day, while those who responded well again had tapered over a median of seven days.5PubMed Central. Lithium-discontinuation-induced treatment refractoriness revisited That might seem fast by today’s standards, and most clinicians recommend considerably longer. A common clinical approach is to reduce the dose by small increments every two to four weeks, spreading the total taper over at least two to four months, sometimes longer for people who have been on lithium for years.
A large study of people who discontinued lithium found that rapid treatment discontinuation was one of the strongest independent predictors of relapse within the first year. This held true even after controlling for diagnosis, illness severity, and how long someone had been treated. Notably, the length of time a person had been on lithium did not independently predict relapse, but how fast they stopped did.6PubMed. Risk factors for early recurrence after discontinuing lithium in bipolar disorder The clinical takeaway is that speed of taper is one of the few modifiable risk factors you have during discontinuation.
Who Is Most Vulnerable to Relapse
Not everyone faces the same odds. Several factors shape how likely a relapse is after stopping lithium. The study just mentioned found that people with bipolar I disorder (as opposed to bipolar II), those with greater illness burden while on lithium, and those who stopped for medical rather than personal reasons were all at higher risk for early recurrence.6PubMed. Risk factors for early recurrence after discontinuing lithium in bipolar disorder People who had more hospital admissions before starting lithium also tended to fare worse. In one elderly cohort, those who relapsed after stopping lithium had been on the drug significantly longer than those who stayed well, and showed a trend toward more prior hospitalizations.7PubMed. Discontinuation of lithium augmentation in an elderly cohort
The reason for stopping matters too. Someone stopping because of side effects they find intolerable is in a very different position from someone being taken off lithium urgently because their kidneys are failing. Medical discontinuation often happens faster and with less flexibility to slow down, which compounds the risk. If you have a choice about the pace, using that choice to taper slowly is the single most protective thing you can do.
Withdrawal Symptoms or Relapse
One of the more confusing aspects of coming off lithium is figuring out what is happening when you start feeling different. Are you experiencing withdrawal symptoms from the drug itself, or is your underlying illness returning? This question has been debated for decades, and the honest answer is that the line is blurry. A review of the literature found that reported symptoms after lithium discontinuation include heightened anxiety, sleep disruption, and irritability, but the authors noted that whether these represent true pharmacological withdrawal (the way someone might experience benzodiazepine withdrawal) or early signs of mood episode recurrence remains controversial.8PubMed Central. Lithium discontinuation: withdrawal or relapse?
In practice, the distinction matters less than you might think. Whether new anxiety or sleeplessness is “withdrawal” or “your bipolar disorder reasserting itself,” the response is the same: tell your prescriber, don’t push through if things are getting worse, and keep the option open to slow or pause the taper. Treating the process as a fixed timeline you must complete is a mistake. A taper should be responsive to how you are actually doing, not just a countdown on a calendar.
The Risk of Lithium Not Working Again
One of the most consequential and underappreciated aspects of lithium discontinuation is the possibility that if you stop and later need to restart, the drug may not work as well as it did before. This phenomenon, called discontinuation-induced refractoriness, is not universal, but it is real enough to factor into any decision about stopping.
A pooled analysis of cohort studies found that roughly 17% of people who restarted lithium after a break were non-responders the second time around. Non-response was associated with having had bipolar illness for a longer time before first starting lithium, a longer gap off the drug, and a faster taper.5PubMed Central. Lithium-discontinuation-induced treatment refractoriness revisited However, the evidence is not entirely one-sided. A separate review of the literature found mixed results: two studies suggested lithium was less effective after an interruption, but three others found no decrease in effectiveness. When the data were pooled, the odds ratio for experiencing more relapses after a treatment break compared to continuous use was 1.40, but this was not statistically significant.9PubMed. The effectiveness of restarted lithium treatment after discontinuation: reviewing the evidence for discontinuation-induced refractoriness And one study looking at actual illness burden before and after a treatment gap found morbidity was similar in both periods, with no clear effect of discontinuation speed, treatment length, or time off the drug.10PubMed. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders
So the picture is genuinely uncertain. About one in six people may lose their response, and a faster taper seems to raise that risk, but it is not a sure thing. The practical implication is that if lithium has been working well for you and the reason for stopping is not urgent, that track record is something to weigh carefully. Losing a good response is a cost that is hard to reverse.
Suicide Risk During Discontinuation
Lithium has an unusually strong anti-suicidal effect compared to other mood stabilizers, and that protective effect disappears when the drug is stopped. In the first year off lithium, one study found that suicidal acts increased roughly twentyfold, and fatalities were fourteen times more frequent than during treatment. Critically, slow discontinuation cut early morbidity by about half and suicidal risk by about half compared to rapid discontinuation.11PubMed. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders A separate study of patients with prior suicide attempts found that suicide risk was twenty-four times higher during periods off adequate lithium prophylaxis compared to periods on it, and that the rate of suicide attempts after stopping was similar to what it had been before lithium was ever started.12PubMed. Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts
These numbers should not be read as a reason to never stop lithium. Sometimes stopping is medically necessary or personally important. But they underscore why close psychiatric follow-up during and after tapering is essential, and why people with a history of suicidal thinking or behavior need an especially careful plan. A safety net of frequent check-ins, a crisis plan, and possibly a transition to another mood stabilizer before lithium is fully removed can make a significant difference.
What Happens to Your Kidneys After Stopping
Many people come off lithium specifically because of concerns about kidney function, and the good news is that the kidneys tend to recover, at least partially. Before discontinuation, kidney function (measured by eGFR) in one large study was declining at an average rate of about 1.6 units per year. After lithium was stopped, that decline essentially halted, dropping to nearly zero over the following five years. The effect was most dramatic in people who already had the most kidney impairment at the time of stopping.13PubMed Central. Kidney function decline improves after lithium discontinuation A second study confirmed this pattern, finding that most people with moderate or worse chronic kidney disease showed either an improvement in kidney function or at least a slower rate of decline after stopping lithium.14PubMed. Renal function after withdrawal of lithium
Interestingly, in the first study, 48 people eventually restarted lithium after a median of about six months off it. Their kidney function promptly resumed declining at the same rate as before, confirming that lithium itself was driving the change.13PubMed Central. Kidney function decline improves after lithium discontinuation This gives a clear answer to a common question: yes, stopping lithium protects kidney function, and the benefit persists. But the tradeoff with psychiatric stability remains. People whose kidneys are declining but whose bipolar illness is well controlled on lithium face a genuinely difficult decision, and it is one where nephrology and psychiatry need to collaborate rather than each specialty making recommendations in isolation.
Thyroid Recovery After Stopping
Lithium commonly suppresses thyroid function, and many people on lithium take thyroid supplementation as a result. After stopping lithium, thyroid markers tend to normalize fairly quickly. In one study, thyroxine (T4) levels rose significantly within one month of discontinuation, and TSH levels dropped, both moving back toward normal. Cortisol levels did not change meaningfully.15Journal of Affective Disorders. The effects of lithium discontinuation and the non-effect of oral inositol upon thyroid hormones and cortisol in patients with bipolar affective disorder If you are taking levothyroxine because of lithium-induced hypothyroidism, your prescriber will likely want to recheck thyroid levels a few weeks after stopping lithium, because your supplementation dose may need to come down or be discontinued as well.
Pregnancy and Lithium Discontinuation
Pregnancy is one of the most common situations in which lithium discontinuation is considered. Lithium carries a known risk of fetal cardiac malformations, particularly when exposure occurs in the first trimester. International guidelines suggest that if a woman on lithium becomes pregnant and is currently well, stopping the medication gradually over about four weeks is reasonable. However, stopping does not eliminate risk that may have already occurred from early exposure, and the risk of relapse, particularly in the postnatal period, is substantial for women with bipolar disorder.16Medsafe. Lithium and pregnancy
This is a situation where the competing risks are starkly real. A manic or depressive episode during pregnancy or the postpartum period carries its own serious dangers for both the parent and the child. Some women and their doctors decide to stay on lithium through pregnancy, accepting the cardiac risk in exchange for psychiatric stability; others choose to stop and plan for close monitoring and rapid reintroduction if needed. There is no universally right answer, only a careful weighing of individual circumstances.
Why People Stop and How the Decision Gets Made
Understanding why people stop lithium helps put the tapering process in context. In a large retrospective study of over 870 patients, more than half eventually discontinued lithium. The most common reason was side effects, accounting for about 62% of discontinuation episodes. The most frequent complaints were gastrointestinal issues like diarrhea (13% of episodes), tremor (11%), excessive thirst or urination (9%), rising creatinine (9%), and weight gain (7%). Psychiatric reasons, including feeling the medication was not effective enough, accounted for about 44% of episodes. Women were as likely as men to take the initiative to stop but were twice as likely to consult a doctor first.17PubMed Central. Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study
The fact that many people stop on their own, without medical guidance, is a serious concern given everything described above. Abrupt self-discontinuation is the most dangerous way to stop. If side effects are driving the decision, there are often intermediate steps worth trying first, like dose adjustment, extended-release formulations, or managing specific symptoms (propranolol for tremor, for instance). When the decision to stop is firm, doing it collaboratively with a prescriber dramatically changes the risk profile.
Practical Approaches to Achieving Small Doses
One logistical challenge of a slow taper is that lithium comes in standard tablet sizes, typically 150 mg, 300 mg, or 450 mg. Getting down to very small doses at the end of a taper can be awkward. Hyperbolic tapering, where dose reductions are proportional rather than fixed (so each step is a percentage of the current dose rather than a flat number of milligrams), is increasingly recommended for psychiatric medications because the brain’s response to dose changes is not linear. Small changes at lower doses have outsized effects compared to the same absolute change at higher doses.
Research on the practical methods for achieving these small final doses found that all common approaches, including splitting tablets, using liquid formulations with a dosing syringe, and dissolving tablets in water, produced doses within an acceptable range. However, precision varied. Tablet splitting and drop-based measurements had higher variability (about 8% relative standard deviation), while using whole tablets, a dosing syringe, or diluted liquid formulations was considerably more precise (about 3.3%).18Cambridge University Press / The British Journal of Psychiatry. Experimental evaluation of guideline-recommended pharmaceutical manipulations for hyperbolic tapering of psychiatric drugs Lithium citrate liquid, which is available by prescription, is the easiest way to make very small dose adjustments. If that is not available, dissolving a tablet in a measured volume of water and using a syringe to draw a specific fraction is a reasonable alternative, though it should be done with guidance from a pharmacist.
For the final stages of a taper, when doses are very low, even small variations can matter more to how you feel. Discussing the method with your prescriber and pharmacist before you get to that point avoids scrambling for solutions at the most sensitive part of the process.
Switching to Another Mood Stabilizer During the Taper
Coming off lithium does not have to mean going without a mood stabilizer entirely. For many people, the plan involves cross-tapering: starting a different medication (valproate, lamotrigine, or an atypical antipsychotic like quetiapine) before lithium is fully removed, so there is no unprotected gap. This is especially relevant for people with bipolar I disorder or a history of severe episodes, where the relapse risk during any unmedicated window is high.
Cross-tapering introduces its own complexities. The replacement medication needs time to reach a therapeutic level, and some drugs (lamotrigine in particular) require a slow upward titration to avoid serious side effects. This means the planning needs to start well before the lithium taper begins. If you and your prescriber decide that a medication-free period is the goal, the monitoring plan needs to account for the heightened vulnerability during and immediately after the taper. Regular follow-up appointments, mood tracking, sleep hygiene, and a clear plan for what constitutes a warning sign worth acting on are all part of the infrastructure that makes discontinuation safer.
People who stop lithium because they feel well and question whether they still need it deserve a candid conversation about what “feeling well” on lithium actually means. Stability on the drug does not prove stability without it; in fact, the data suggest the opposite. That does not mean the decision to try discontinuation is always wrong, but it means going in with clear expectations, a slow taper, and a genuine willingness to reverse course if things start sliding.